Page 145 - FINAL PROGRAMME 2017
P. 145

WEDNESDAY, 5 JULY 2017
SELECTED ORAL COMMUNICATIONS
10:00 - 11:45 Plenary 2
Session 62: Mutations and primary ovarian insuf ciency
Chairman: R. Fanchin (France) Chairman: D. Wirthner (Switzerland)
10:00 O-228
10:15 O-229
Health and morbidity of women with POI due to FSH resistant ovaries
K. Luiro1, K. Aittomäki2, J.S. Tapainainen3
1Helsinki University Hospital and University of Helsinki, Dept of Obstetrics and Gynecology, Helsinki, Finland
2Helsinki University Hospital and University of Helsinki, Dept of Clinical Genetics, Helsinki, Finland
3Helsinki University Hospital and University of Helsinki, Dept of Obstetics and Gynecology, Helsinki, Finland
POR mutations as novel genetic causes of female infertility due to partial 17 alpha- hydroxylase de ciency
K. Saito1,2, K. Kawai2,3, K. Tatsumi4, M. Miyado5, M. Katsumi1, S. Nakamura1,6, T. Ishikawa2, N. Miyasaka2, M. Fukami1
1National Research Institute for Child Health and Development, Department of Molecular Endocrinology, Tokyo, Japan
2Graduate School- Tokyo Medical and Dental University, Department of Comprehensive Reproductive Medicine, Tokyo, Japan
3Kameda Medical Center, Department of Reproductive Medicine, Chiba, Japan 4Umegaoka Women's Clinic, Tokyo, Japan
5National Research Institute for Child Health and Developent, Department of Molecular Endocrinology, Tokyo, Japan
6Jichi Medical University- Children's Medical Center Tochigi, Department of Pediatric Urology, Tochigi, Japan
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 145
SCIENTIFIC PROGRAMME WEDNESDAY, 5 JULY


































































































   143   144   145   146   147